Eloxx Pharmaceuticals, Inc. (ELOX): Price and Financial Metrics
GET POWR RATINGS... FREE!
ELOX Stock Price Chart Interactive Chart >
ELOX Price/Volume Stats
|Current price||$1.93||52-week high||$6.77|
|Prev. close||$1.90||52-week low||$1.34|
|Day high||$1.93||Avg. volume||754,377|
|50-day MA||$2.08||Dividend yield||N/A|
|200-day MA||$3.02||Market Cap||92.36M|
Eloxx Pharmaceuticals, Inc. (ELOX) Company Bio
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel therapeutics for the treatment of rare and ultra-rare premature stop codon diseases. Its lead program is ELX-02, which is in Phase I clinical trial, which focuses on the treatment of cystic fibrosis and cystinosis patients with diagnosed nonsense mutations. The company was founded in 2013 and is based in Waltham, Massachusetts.
ELOX Latest News Stream
|Loading, please wait...|
ELOX Latest Social Stream
View Full ELOX Social Stream
Latest ELOX News From Around the Web
Below are the latest news stories about Eloxx Pharmaceuticals Inc that investors may wish to consider to help them evaluate ELOX as an investment opportunity.
We've got one more day of trading left in the week and we're starting it off with the biggest-pre-market stock movers for Friday!
Investors need to pay close attention to Eloxx Pharmaceuticals (ELOX) stock based on the movements in the options market lately.
Investors need to pay close attention to Eloxx (ELOX) stock based on the movements in the options market lately.
We're getting you ready for the last day of trading this week with a look at the biggest pre-market stock movers for Friday!
Eloxx Pharmaceuticals (ELOX) commenced an underwritten public offering of shares; underwriters granted 30-day option to purchase up to an additional 15% of the shares.Offer size, terms not yet disclosed....
ELOX Price Returns